SWEDENCARE AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.1 SEK | -0.88% |
|
-2.35% | -7.89% |
| 25/04 | Swedencare AB Approves Dividend for the Year 2023, Payable on May 3, 2024 | CI |
| 25/04 | Transcript : Swedencare AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,463 | 6,273 | 18,183 | 4,862 | 9,676 | 8,984 | - | - |
| Enterprise Value (EV) 1 | 1,419 | 6,142 | 18,664 | 6,519 | 11,098 | 9,985 | 9,472 | 8,889 |
| P/E ratio | 48.7 x | 116 x | 314 x | 50.4 x | 165 x | 39.4 x | 26.2 x | 19.3 x |
| Yield | - | 0.25% | 0.13% | 0.72% | 0.38% | 0.88% | 1.41% | 1.94% |
| Capitalization / Revenue | 11.5 x | 26.1 x | 23.6 x | 2.66 x | 4.16 x | 3.38 x | 2.99 x | 2.66 x |
| EV / Revenue | 11.2 x | 25.6 x | 24.2 x | 3.56 x | 4.77 x | 3.75 x | 3.16 x | 2.63 x |
| EV / EBITDA | 35.9 x | 87.4 x | 144 x | 17.1 x | 22.2 x | 14.7 x | 12.1 x | 8.94 x |
| EV / FCF | 50.7 x | -10.4 x | -10.7 x | -1.48 x | 41.5 x | 17.5 x | 14.6 x | 11.7 x |
| FCF Yield | 1.97% | -9.59% | -9.34% | -67.6% | 2.41% | 5.72% | 6.87% | 8.52% |
| Price to Book | 11.1 x | 7.28 x | 7.51 x | 0.65 x | 1.34 x | 1.14 x | 1.1 x | 1.06 x |
| Nbr of stocks (in thousands) | 79,010 | 96,510 | 1,18,150 | 1,58,112 | 1,58,732 | 1,58,732 | - | - |
| Reference price 2 | 18.52 | 65.00 | 153.9 | 30.75 | 60.96 | 56.60 | 56.60 | 56.60 |
| Announcement Date | 13/02/20 | 18/02/21 | 06/04/22 | 16/02/23 | 15/02/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 126.8 | 239.9 | 770.4 | 1,829 | 2,325 | 2,659 | 3,000 | 3,375 |
| EBITDA 1 | 39.53 | 70.3 | 129.7 | 380.7 | 499.3 | 680.2 | 783.7 | 994.8 |
| EBIT 1 | 36.91 | 60.37 | 64.56 | 120 | 184.2 | 372.3 | 541.6 | 657.5 |
| Operating Margin | 29.12% | 25.16% | 8.38% | 6.56% | 7.92% | 14% | 18.06% | 19.48% |
| Earnings before Tax (EBT) 1 | 36.69 | 58.67 | 56.9 | 80.09 | 81.1 | 291.9 | 439.7 | 596.7 |
| Net income 1 | 29.91 | 48.53 | 54.62 | 94.45 | 58.6 | 227.8 | 342.9 | 465.5 |
| Net margin | 23.6% | 20.23% | 7.09% | 5.16% | 2.52% | 8.57% | 11.43% | 13.79% |
| EPS 2 | 0.3800 | 0.5600 | 0.4900 | 0.6100 | 0.3700 | 1.435 | 2.160 | 2.932 |
| Free Cash Flow 1 | 28.02 | -589.1 | -1,743 | -4,406 | 267.6 | 571.1 | 650.3 | 757.5 |
| FCF margin | 22.1% | -245.5% | -226.22% | -240.84% | 11.51% | 21.47% | 21.68% | 22.44% |
| FCF Conversion (EBITDA) | 70.87% | - | - | - | 53.6% | 83.96% | 82.97% | 76.15% |
| FCF Conversion (Net income) | 93.65% | - | - | - | 456.66% | 250.65% | 189.63% | 162.74% |
| Dividend per Share 2 | - | 0.1600 | 0.2000 | 0.2200 | 0.2300 | 0.5000 | 0.8000 | 1.100 |
| Announcement Date | 13/02/20 | 18/02/21 | 06/04/22 | 16/02/23 | 15/02/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 255.2 | 380.2 | 470.9 | 483.5 | 497.4 | 523.6 | 572.1 | 602 | 627.2 | 598.9 | 664 | 691 | 707 |
| EBITDA 1 | 3.662 | 94.7 | 118.6 | 83.81 | 112.3 | 107.4 | 119.5 | 137 | 135.5 | 138.8 | 167.1 | 185.9 | 195.9 |
| EBIT 1 | -57.77 | 74.98 | 107.3 | 21.64 | 35.28 | 30.3 | 30.9 | 56.7 | 55.3 | 62 | 90.29 | 109.1 | 119.1 |
| Operating Margin | -22.64% | 19.72% | 22.79% | 4.48% | 7.09% | 5.79% | 5.4% | 9.42% | 8.82% | 10.35% | 13.6% | 15.79% | 16.85% |
| Earnings before Tax (EBT) 1 | -59.38 | 2.675 | 32.93 | 11.8 | 17.69 | 10.2 | 9.8 | 32.8 | 28.3 | 35.1 | 68.83 | 88.47 | 99.39 |
| Net income 1 | -34.34 | 11.53 | 77.63 | 24.29 | 15.78 | 17.2 | 16.3 | 38.1 | -13 | 30.1 | 53 | 68.12 | 76.53 |
| Net margin | -13.46% | 3.03% | 16.49% | 5.02% | 3.17% | 3.28% | 2.85% | 6.33% | -2.07% | 5.03% | 7.98% | 9.86% | 10.82% |
| EPS 2 | -0.3200 | 0.0800 | 0.4900 | 0.1500 | 0.1000 | 0.1100 | 0.1000 | 0.2400 | -0.0800 | 0.1900 | 0.3339 | 0.4292 | 0.4821 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 06/04/22 | 12/05/22 | 28/07/22 | 09/11/22 | 16/02/23 | 28/04/23 | 27/07/23 | 25/10/23 | 15/02/24 | 25/04/24 | - | - | - |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 481 | 1,657 | 1,421 | 1,000 | 488 | - |
| Net Cash position 1 | 43.8 | 131 | - | - | - | - | - | 95.2 |
| Leverage (Debt/EBITDA) | - | - | 3.707 x | 4.352 x | 2.847 x | 1.471 x | 0.6226 x | - |
| Free Cash Flow 1 | 28 | -589 | -1,743 | -4,406 | 268 | 571 | 650 | 758 |
| ROE (net income / shareholders' equity) | 26.1% | 9.12% | 3.27% | 1.91% | 0.91% | 3.02% | 4.27% | 5.58% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 1.660 | 8.930 | 20.50 | 47.00 | 45.40 | 49.80 | 51.50 | 53.60 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 5.11 | 620 | 27.8 | 4,666 | 176 | 68.7 | 75.3 | 81 |
| Capex / Sales | 4.03% | 258.25% | 3.61% | 255.06% | 7.59% | 2.58% | 2.51% | 2.4% |
| Announcement Date | 13/02/20 | 18/02/21 | 06/04/22 | 16/02/23 | 15/02/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
56.6
SEK
Average target price
67
SEK
Spread / Average Target
+18.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.89% | 819M | |
| -11.74% | 6.48B | |
| +24.75% | 3.7B | |
| -2.92% | 3.1B | |
| -0.34% | 1.44B | |
| -15.13% | 1.37B | |
| -25.63% | 1.24B | |
| -6.93% | 1.19B | |
| -10.84% | 1.17B | |
| -.--% | 1.05B |
- Stock Market
- Equities
- SECARE Stock
- Financials Swedencare AB
